Development of a Reverse-Phase High-Performance Liquid Chromatography Method for Simultaneous Quantification of Tofacitinib Citrate and Berberine Chloride in Bulk, Injection and Plasma
Journal of Chromatographic Science · 2026
DOI: 10.1093/chromsci/bmag010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2026. Verfasst von Monika und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanotheranostic Laboratory, Department of Pharmacy, School of Healthcare and Allied Sciences, GD Goenka University, Sohna, Gurugram Road, Haryana 122…. Hauptthemen laut MEDLINE: Chromatography, Reverse-Phase, Pyrimidines, Berberine, Piperidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
The main aim of this study was to develop and validate a new reverse-phase high-performance liquid chromatography (RP-HPLC) method for the simultaneous estimation of tofacitinib citrate (TFC) and berberine chloride (BBC) in pharmaceutical injection formulations and blood plasma. An isocratic RP-HPLC method was used with a mobile phase consisting of phosphate buffer saline (pH 5.5) and acetonitrile at a ratio of 70:30, at flow rate of 1 mL/min at 25°C. Both drugs were detected at 306 nm. The proposed method demonstrated excellent linearity over a concentration range of 5–30 μg/mL for both the TFC and BBC, with correlation coefficients (R2) exceeding 0.999. System suitability parameters, including peak area, tailing factor, theoretical plates and resolution, were within acceptable limits, with relative standard deviations <2%. The recovery studies at 50, 100 and 150% showed mean recovery rates of 99.4–100.7% for TFC and 99.9–100.4% for BBC. The method exhibited high sensitivity, with low detection and quantification limits. The robustness was confirmed under slight variations in flow rate and mobile phase composition. The developed RP-HPLC method is accurate, reliable and suitable for simultaneous quantification of TFC and BBC in pharmaceutical and biological matrices, offering potential for routine quality control and pharmacokinetic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nanotheranostic Laboratory, Department of Pharmacy, School of Healthcare and Allied Sciences, GD Goenka University, Sohna, Gurugram Road, Haryana 122103, India.
- HIMT College of Pharmacy, Knowledge Park - 1, Greater Noida, Gautam Buddha Nagar, Uttar Pradesh 201310, India.
- Chitkara College of Pharmacy, Chitkara University, Chandigarh, Patiala National Highway, Punjab 140401, India.
- Department of Pharmacy, Guru Teg Bahadur Hospital, Dilshad Garden, New Delhi 110095, India.
- National Dendrimer and Nanotechnology Center, 2625 Denison Drive, Mount Pleasant, MI 48858, USA.
- College of Medicine, Central Michigan University, Mount Pleasant, MI 48859, USA.
ORCID-Profile: Rahul Pratap Singh
Zitieren
APA
Monika, Jhawat, V., Chauhan, M., Chauhan, S., Sonali, Singh, M. K., Singh, R., & Singh, R. P. (2026). Development of a Reverse-Phase High-Performance Liquid Chromatography Method for Simultaneous Quantification of Tofacitinib Citrate and Berberine Chloride in Bulk, Injection and Plasma. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmag010
Vancouver
Monika, Jhawat V, Chauhan M, Chauhan S, Sonali, Singh MK, et al. Development of a Reverse-Phase High-Performance Liquid Chromatography Method for Simultaneous Quantification of Tofacitinib Citrate and Berberine Chloride in Bulk, Injection and Plasma. Journal of Chromatographic Science. 2026. doi:10.1093/chromsci/bmag010
BibTeX
@article{Monika2026,
author = {Monika and Jhawat, Vikas and Chauhan, Mahima and Chauhan, Samrat and Sonali and Singh, Mayank Kumar and Singh, Rahul and Singh, Rahul Pratap},
title = {Development of a Reverse-Phase High-Performance Liquid Chromatography Method for Simultaneous Quantification of Tofacitinib Citrate and Berberine Chloride in Bulk, Injection and Plasma},
journal = {Journal of Chromatographic Science},
year = {2026},
doi = {10.1093/chromsci/bmag010}
}
EUVIMED